Recent advances in bladder cancer treatments may offer hope of curative care to more patients, including those with high-risk localized, muscle-invasive disease, according to an editorial published in ...
Reducing the risk of metastatic relapse in patients with resectable soft tissue sarcomas is crucial for improving outcomes, because metastasis is the primary cause of mortality in this population.
“Onco360 is grateful for the opportunity to partner with the team at Genentech and become a specialty pharmacy provider for Itovebi ™ ,” said Benito Fernandez. “We are proud to add another treatment ...
Global Breast Cancer Screening Tests Market was valued at approximately USD 2.93 billion in 2023 and is projected to grow with a healthy CAGR of 54.3% over the forecast period 2024-2032. Read the ...
The Global Cementless Total Knee Arthroplasty Market was valued at approximately USD 1.99 billion in 2023 and is projected to expand at a compound annual growth rate (CAGR) of 4.6% over the forecast ...
The 2-year progression free survival was improved with the addition of toripalimab (92·0% [95% CI 86·7–97·3]) compared with placebo (74·0% [61·8–86·2]; stratified hazard ratio 0·40 [95% CI 0·18–0·89]; ...